Gt Biopharma Inc (GTBP)

Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Selling, General, and Administrative	27.77% 2.314	1.811	1.758	1.526	2.015
Operating Income/Loss	2.43% -3.091	-3.168	-3.122	-3.621	-3.665
Nonoperating Income/Loss	300.49% 0.825	0.206	0.706	1.629	3.438
Income/Loss From Continuing Operations Before Tax	23.50% -2.266	-2.962	-2.416	-1.992	-0.227
Income/Loss From Continuing Operations After Tax	23.50% -2.266	-2.962	-2.416	-1.992	-0.227
Net Income/Loss	23.50% -2.266	-2.962	-2.416	-1.992	-0.227
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	103.56% 1.3806	-38.75	41.02	40.17	39.09
Diluted Average Shares	103.56% 1.3806	-38.75	41.02	40.17	-0.5405
Basic Earnings Per Share	70.29% -1.64	-5.52	-0.06	-0.05	-0.01
Diluted Earnings Per Share	70.29% -1.64	-5.52	-0.06	-0.05	-0.010
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-